Developing small molecule therapeutics for the treatment of cancer.
Industry: Health Care
First Day Return: 0.0%
IPO Data | |
---|---|
IPO Date | 12/11/2013 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $50 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | Malvern, PA, United States |
Founded | 2001 |
Employees at IPO | 20 |
Website www.tetralogicpharma.com |